Building Stress Resilience with Ashwagandha: Supporting Your Body’s Adaptability in Midlife
Stress resilience is a measurable adaptation, not a mood. How ashwagandha’s cortisol and perceived stress data map onto the demands of midlife.
Stress resilience is a measurable adaptation, not a mood. How ashwagandha’s cortisol and perceived stress data map onto the demands of midlife.
Ashwagandha is a root, not a food crop, so dietary sources are effectively limited to preparations of the plant itself. What that means in practice.
Magnesium works on the GABA and NMDA pathway, ashwagandha on cortisol. Which one fits perimenopausal insomnia depends on why you are waking up.
Documented ashwagandha liver injury cases exist and are rare but real. What the case reports actually describe, and the warning signs worth knowing.
Ashwagandha trials in active adults show gains in VO2 max, strength and recovery markers. How much of that is likely to transfer to perimenopausal training.
Ashwagandha and alcohol share sedative pathways and both load the liver. Why the combination raises drowsiness and hepatic risk more than either alone.
Gastrointestinal upset is the most reported ashwagandha side effect in women, and it is dose-linked. What else shows up, and when it means stopping.
Perimenopausal fatigue has several drivers and cortisol is only one. Where ashwagandha’s stamina and VO2 max data is genuinely suggestive, and where it is thin.